ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, Vinot S, Bièche I, Grisard E, Josserand V, Coll JL, Roux P, Corbo L, Treilleux I, Rimokh R, Cohen PA.
Vendrell JA, et al. Among authors: rimokh r.
Cancer Res. 2012 Jul 15;72(14):3593-606. doi: 10.1158/0008-5472.CAN-11-3095. Epub 2012 May 16.
Cancer Res. 2012.
PMID: 22593193